C. J. Choy

发表

Structure–Activity Relationship of 18F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer

H. VanBrocklin, Christopher R. Drake, E. Jones, 2018 .

Phosphoramidate derivates as controlled-release prodrugs of l-Dopa.

C. Berkman, C. J. Choy, F. Olatunji, 2019, Bioorganic & medicinal chemistry letters.

Stereoselective inhibition of glutamate carboxypeptidase by organophosphorus derivatives of glutamic acid.

Ying Hu, S. Pavkovic, C. Berkman, 2004, Bioorganic & medicinal chemistry.

Synthesis of individual glutamate-containing phosphonamidothionate stereoisomers

Ying Hu, C. Berkman, J. Mallari, 2001 .

Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities

J. Lubkowski, J. Černý, C. Bařinka, 2016, The FEBS journal.

Tunable pH-Sensitive 2-Carboxybenzyl Phosphoramidate Cleavable Linkers.

Brian S. Backer, C. Berkman, C. J. Choy, 2020, Tetrahedron letters.

Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403

C. Laymon, B. Kurland, L. Rigatti, 2019, Molecular Imaging and Biology.

177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice

C. Anderson, C. Berkman, Joseph D Latoche, 2017, Theranostics.

Evaluation of Diarylureas for Activity Against Plasmodium falciparum.

J. Derisi, R. Guy, J. L. Weisman, 2010, ACS medicinal chemistry letters.

Second-Generation Tunable pH-Sensitive Phosphoramidate-Based Linkers for Controlled Release.

Brian S. Backer, B. Clowers, C. Berkman, 2016, Bioconjugate chemistry.

Tunable pH-Sensitive Linker for Controlled Release.

C. Berkman, Jonathan J. Geruntho, C. J. Choy, 2016, Bioconjugate chemistry.

Crystal Structure of Phosphoserine BlaC from Mycobacterium tuberculosis Inactivated by Bis(Benzoyl) Phosphate

C. Kang, C. Berkman, D. White, 2019, International journal of molecular sciences.

Rationally Designed Sulfamides as Glutamate Carboxypeptidase II Inhibitors

Marc O. Anderson, Joseph K. Choi, C. Berkman, 2013, Chemical biology & drug design.

177 Lu-Labeled Phosphoramidate-Based PSMA Inhibitors : The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice

C. Anderson, C. Berkman, Joseph D Latoche, 2017 .

Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer.

H. VanBrocklin, Christopher R. Drake, E. Jones, 2016, Journal of medicinal chemistry.

Synthesis of Amino Acid Phosphoramidate Monoesters via H‐Phosphonate Intermediates

C. Wagner, C. J. Choy, Dan P. Drontle, 2006, Current protocols in nucleic acid chemistry.

GENERATION OF AZT H-PHOSPHONATE WITH DIPHENYL PHOSPHITE AND ITS CONVERSION TO AZT AMINO ACID PHOSPHORAMIDATE METHYL AMIDES

C. J. Choy, Dan P Drontle, 2006 .

A method to determine the mode of binding for GCPII inhibitors using bio-layer interferometry

C. Berkman, C. J. Choy, 2016, Journal of Enzyme Inhibition and Medicinal Chemistry.

Structure − Activity Relationship of 18 F ‐ Labeled Phosphoramidate Peptidomimetic Prostate-Speci fi c Membrane Antigen ( PSMA )-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer

H. VanBrocklin, Christopher R. Drake, E. Jones, 2016 .

Bis(benzoyl) phosphate inactivators of beta-lactamase C from Mtb.

C. Kang, C. Berkman, D. White, 2019, Bioorganic & medicinal chemistry letters.

Second-Generation Tunable pH-Sensitive Phosphoramidate-Based Linkers for Controlled Release.

Brian S. Backer, B. Clowers, C. Berkman, 2016, Bioconjugate chemistry.

Structural, Biochemical, and Computational Characterization of Sulfamides as Bimetallic Peptidase Inhibitors

C. Bařinka, L. Motlová, Z. Nováková, 2024, J. Chem. Inf. Model..